Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients

Scheiter, Alexander, Mellin, Simon, Keil, Felix, Meier, Johannes P., Heudobler, Daniel, Brummer, Christina, Einhell, Sabine, Zwicker, Benjamin, Wutzlhofer, Elena, Hierl, Frederik, Klemm, Sophie, Lüftl, Elena, Schneider, Tom, Perl, Markus, Klier-Richter, Margit, Immel, Alexander, Kaltofen, Till, Grube, Matthias, Bumes, Elisabeth, Seitz, Stephan, Schulz, Christian, Haferkamp, Sebastian, Drexler, Konstantin, Troeger, Anja, Steger, Felix, Schlosser-Hupf, Sophie, Tews, Hauke Christian, Kandulski, Arne, Wohlfart, Kristina, Erber, Ramona, Schönbuchner, Ines, Lessel, Davor, Schnabel, Marco Julius, Sedlmeier, Anja M., Klinkhammer-Schalke, Monika, Maurer, Julia Karolin, Calvisi, Diego Francesco, Pukrop, Tobias, Kaiser, Ulrich, Hirsch, Daniela, Dietmaier, Wolfgang, Evert, Matthias, Lüke, Florian, Utpatel, Kirsten, :unav

Open source

DOI: 10.24406/publica-9728
Published: 2026
Container: Not recorded
Publisher: Fraunhofer-Gesellschaft
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.24406/publica-9728,
  title = {Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients},
  author = {Scheiter, Alexander and Mellin, Simon and Keil, Felix and Meier, Johannes P. and Heudobler, Daniel and Brummer, Christina and Einhell, Sabine and Zwicker, Benjamin and Wutzlhofer, Elena and Hierl, Frederik and Klemm, Sophie and Lüftl, Elena and Schneider, Tom and Perl, Markus and Klier-Richter, Margit and Immel, Alexander and Kaltofen, Till and Grube, Matthias and Bumes, Elisabeth and Seitz, Stephan and Schulz, Christian and Haferkamp, Sebastian and Drexler, Konstantin and Troeger, Anja and Steger, Felix and Schlosser-Hupf, Sophie and Tews, Hauke Christian and Kandulski, Arne and Wohlfart, Kristina and Erber, Ramona and Schönbuchner, Ines and Lessel, Davor and Schnabel, Marco Julius and Sedlmeier, Anja M. and Klinkhammer-Schalke, Monika and Maurer, Julia Karolin and Calvisi, Diego Francesco and Pukrop, Tobias and Kaiser, Ulrich and Hirsch, Daniela and Dietmaier, Wolfgang and Evert, Matthias and Lüke, Florian and Utpatel, Kirsten and :unav},
  year = {2026},
  doi = {10.24406/publica-9728},
  url = {https://doi.org/10.24406/publica-9728}
}

RIS

TY  - JOUR
TI  - Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
AU  - Scheiter, Alexander
AU  - Mellin, Simon
AU  - Keil, Felix
AU  - Meier, Johannes P.
AU  - Heudobler, Daniel
AU  - Brummer, Christina
AU  - Einhell, Sabine
AU  - Zwicker, Benjamin
AU  - Wutzlhofer, Elena
AU  - Hierl, Frederik
AU  - Klemm, Sophie
AU  - Lüftl, Elena
AU  - Schneider, Tom
AU  - Perl, Markus
AU  - Klier-Richter, Margit
AU  - Immel, Alexander
AU  - Kaltofen, Till
AU  - Grube, Matthias
AU  - Bumes, Elisabeth
AU  - Seitz, Stephan
AU  - Schulz, Christian
AU  - Haferkamp, Sebastian
AU  - Drexler, Konstantin
AU  - Troeger, Anja
AU  - Steger, Felix
AU  - Schlosser-Hupf, Sophie
AU  - Tews, Hauke Christian
AU  - Kandulski, Arne
AU  - Wohlfart, Kristina
AU  - Erber, Ramona
AU  - Schönbuchner, Ines
AU  - Lessel, Davor
AU  - Schnabel, Marco Julius
AU  - Sedlmeier, Anja M.
AU  - Klinkhammer-Schalke, Monika
AU  - Maurer, Julia Karolin
AU  - Calvisi, Diego Francesco
AU  - Pukrop, Tobias
AU  - Kaiser, Ulrich
AU  - Hirsch, Daniela
AU  - Dietmaier, Wolfgang
AU  - Evert, Matthias
AU  - Lüke, Florian
AU  - Utpatel, Kirsten
AU  - :unav
PY  - 2026
DO  - 10.24406/publica-9728
UR  - https://doi.org/10.24406/publica-9728
ER  -

APA

Alexander, S., Simon, M., Felix, K., P., M. J., Daniel, H., Christina, B., Sabine, E., Benjamin, Z., Elena, W., Frederik, H., Sophie, K., Elena, L., Tom, S., Markus, P., Margit, K., Alexander, I., Till, K., Matthias, G., Elisabeth, B., Stephan, S., Christian, S., Sebastian, H., Konstantin, D., Anja, T., Felix, S., Sophie, S., Christian, T. H., Arne, K., Kristina, W., Ramona, E., Ines, S., Davor, L., Julius, S. M., M., S. A., Monika, K., Karolin, M. J., Francesco, C. D., Tobias, P., Ulrich, K., Daniela, H., Wolfgang, D., Matthias, E., Florian, L., Kirsten, U., & :unav (2026). Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients. https://doi.org/10.24406/publica-9728

Source records

datacite · retrieved 2026-11-08T06:01:03.832Z